查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1212482

幹細胞製造的全球市場

Stem Cell Manufacturing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

幹細胞製造的全球市場2030年將達到207億美元

在COVID-19後改變的商務環境中，2022年112億美元的幹細胞製造的全球市場，分析期間的2022-2030年將以以年複合成長率8％增長，在2030年前將達到207億美元的修正規模。本報告所分析之市場區隔之一的培養基年複合成長率將記錄7.9％，到分析期間結束時達到84億美元。考慮疫情後的復甦趨勢，消耗品領域今後8年的年複合成長率將修正為8.1％。

美國市場估算為33億美元，中國則將以年複合成長率7.5％增長

美國的幹細胞製造市場在2022年估算為33億美元。作為世界第2大經濟大國的中國，從2022年2030年年複合成長率預計將為7.5％，到2030年達到36億美元的市場規模。其他熱門的地區市場有日本和加拿大，在2022年～2030年預計將各以7.1％和6.7％的速度成長。在歐洲市場中，德國將以年複合成長率約6.2％成長。

其他競爭公司的選擇

  • Anterogen
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Cellular Dynamics International
  • Holostem Terapie Avanzate
  • Lonza Group
  • Medipost
  • Merck Group
  • Miltenyi Biotec
  • Osiris Therapeutics
  • Pharmicell
  • Pluristem Therapeutics
  • Stemcell Technologies
  • Takara Bio Group
  • Thermo Fisher Scientific

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22861

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stem Cell Manufacturing Market to Reach $20.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Stem Cell Manufacturing estimated at US$11.2 Billion in the year 2022, is projected to reach a revised size of US$20.7 Billion by 2030, growing at a CAGR of 8% over the analysis period 2022-2030. Culture Media, one of the segments analyzed in the report, is projected to record a 7.9% CAGR and reach US$8.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 8.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 7.5% CAGR

The Stem Cell Manufacturing market in the U.S. is estimated at US$3.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.1% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 33 Featured):

  • Anterogen
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Cellular Dynamics International
  • Holostem Terapie Avanzate
  • Lonza Group
  • Medipost
  • Merck Group
  • Miltenyi Biotec
  • Osiris Therapeutics
  • Pharmicell
  • Pluristem Therapeutics
  • Stemcell Technologies
  • Takara Bio Group
  • Thermo Fisher Scientific

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Stem Cell Manufacturing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Stem Cell Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 3: World 18-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Culture Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 6: World 18-Year Perspective for Culture Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 9: World 18-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 12: World 18-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Stem Cell Lines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 15: World 18-Year Perspective for Stem Cell Lines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 18: World 18-Year Perspective for Research-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cell & Tissue Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 21: World 18-Year Perspective for Cell & Tissue Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 24: World 18-Year Perspective for Clinical-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
    • TABLE 25: World Stem Cell Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 28: USA 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 31: USA 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 34: Canada 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 37: Canada 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • JAPAN
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 40: Japan 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 43: Japan 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • CHINA
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 46: China 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 49: China 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • EUROPE
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Stem Cell Manufacturing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 52: Europe 18-Year Perspective for Stem Cell Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 55: Europe 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 58: Europe 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • FRANCE
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 61: France 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 64: France 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • GERMANY
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 67: Germany 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 70: Germany 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 73: Italy 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 76: Italy 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • UNITED KINGDOM
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 79: UK 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 82: UK 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 85: Rest of Europe 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 88: Rest of Europe 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • ASIA-PACIFIC
    • Stem Cell Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 91: Asia-Pacific 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 94: Asia-Pacific 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Stem Cell Manufacturing by Product - Culture Media, Consumables, Instruments and Stem Cell Lines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 97: Rest of World 18-Year Perspective for Stem Cell Manufacturing by Product - Percentage Breakdown of Value Sales for Culture Media, Consumables, Instruments and Stem Cell Lines for the Years 2012, 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Stem Cell Manufacturing by Application - Research-based, Cell & Tissue Banking and Clinical-based Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
    • TABLE 100: Rest of World 18-Year Perspective for Stem Cell Manufacturing by Application - Percentage Breakdown of Value Sales for Research-based, Cell & Tissue Banking and Clinical-based for the Years 2012, 2023 & 2030

IV. COMPETITION